Core Insights - The article highlights a concerning trend in diabetes prevalence in China, indicating a significant increase in the number of patients and the urgent need for effective prevention and control strategies [9][15]. Group 1: Diabetes Prevalence and Trends - As of 2023, the total number of diabetes patients in China has reached 233 million, with a prevalence rate of 15.88%, marking a 163% increase from 88.48 million patients in 2005 [9][15]. - The age-standardized prevalence rate (ASR) of diabetes has risen from 7.53% in 2005 to 13.67% in 2023, with an annual growth rate of 3.36% [9][10]. - The years of life lost due to disability (YLDs) related to diabetes reached 32.49 million in 2023, reflecting a significant decline in overall health quality among the population [9][10]. Group 2: Regional Distribution and Characteristics - The eastern region of China has the highest number of diabetes patients at 78.47 million, followed by central and northern regions with 53.98 million and 36.06 million patients, respectively [11][12]. - The northern region has the highest ASR at 17.20%, with major cities like Beijing and Tianjin exceeding a 20% prevalence rate due to dietary habits [11][12]. - The southwestern region is experiencing the fastest growth in diabetes prevalence, increasing from 5.65% in 2005 to 11.77% in 2023, driven by changes in dietary patterns [12][13]. Group 3: Future Projections and Strategies - Projections indicate that if current trends continue, the ASR of diabetes could reach 16.15% by 2030, 21.52% by 2040, and potentially 29.10% by 2050, posing unprecedented challenges to the healthcare system [13][15]. - Implementing systematic obesity intervention strategies could significantly improve these projections, potentially keeping the ASR below 15% by 2050, a reduction of 49.10% from the natural trajectory [13][14]. - The article emphasizes the need for differentiated regional strategies in diabetes prevention, focusing on early screening and lifestyle interventions tailored to local conditions [14][16].

Core Viewpoint - The article highlights the alarming increase in diabetes prevalence in China, emphasizing the urgent need for effective prevention and control strategies to address this public health crisis [9][15][16]. Summary by Sections Diabetes Prevalence and Trends - As of 2023, the total number of diabetes patients in China has reached 233 million, with a prevalence rate of 15.88%, marking a 163% increase from 88.48 million patients in 2005 [9][15]. - The age-standardized prevalence rate (ASR) has risen from 7.53% in 2005 to 13.67% in 2023, with an annual growth rate of 3.36% [9][10]. - The years of life lost due to disability (YLDs) related to diabetes reached 32.49 million in 2023, reflecting a significant decline in overall health quality [9]. Regional Distribution and Characteristics - The eastern region has the highest number of diabetes patients at 78.47 million, followed by central and northern regions [11]. - The northern region has the highest ASR at 17.20%, with major cities like Beijing and Tianjin exceeding a 20% prevalence rate [12]. - The southwestern region shows the fastest growth in diabetes prevalence, increasing from 5.65% in 2005 to 11.77% in 2023, driven by dietary changes [12]. Future Projections and Challenges - Projections indicate that if current trends continue, the ASR could reach 16.15% by 2030, 21.52% by 2040, and potentially 29.10% by 2050, adding nearly 150 million new diabetes patients [13][15]. - The healthcare system will face unprecedented pressure due to the high costs associated with diabetes treatment and management [10][15]. Prevention and Control Strategies - The article advocates for a shift from treatment to early screening, lifestyle interventions, and strengthening primary healthcare [10][15]. - A differentiated regional strategy is necessary, focusing on complication management in high-prevalence areas and lifestyle interventions in rapidly growing regions [14][16]. - Implementing obesity intervention strategies could significantly reduce the projected diabetes prevalence by 2050, potentially keeping it below 15% [13][15].

Core Viewpoint - The article highlights the alarming rise in global diabetes prevalence, with over 800 million adults affected, and emphasizes the urgent need for improved public health strategies and early intervention, particularly in high-risk populations like China [5][9][10]. Group 1: Global Diabetes Trends - The total number of global adult diabetes patients has surpassed 800 million, a fourfold increase since 1990, with 4.45 million untreated patients aged 30 and above in 2022 [5][9]. - By 2050, global diabetes patients are projected to exceed 1.31 billion, indicating a significant public health challenge ahead [7]. - The global diabetes prevalence rate increased by 90.5% from 1990 to 2021, rising from 3.2% to 6.1% [7]. Group 2: Diabetes in China - China has 148 million diabetes patients, ranking second globally, with over 52% of these patients untreated [9][10]. - The majority of new diabetes cases in China are type 2 diabetes, accounting for 99.2% of new cases in 2021 [10]. - The gender disparity in diabetes-related health burdens is notable, with men experiencing a higher disability burden compared to women [10]. Group 3: Complications and Healthcare Burden - Approximately 30% to 40% of diabetes patients may develop chronic kidney disease (CKD), with type 2 diabetes being a major contributing factor [8]. - The number of new CKD cases due to type 2 diabetes rose from 1.4 million in 1990 to 2.4 million in 2017, a 74% increase [8]. - The treatment resources for end-stage kidney disease (ESKD) are unevenly distributed globally, with only 27% to 53% of patients receiving necessary care [8]. Group 4: Prevention and Control Strategies - The updated "China Diabetes Prevention and Control Guidelines (2024)" indicates a continuous rise in diabetes prevalence, necessitating enhanced screening and diagnostic measures [11][12]. - The national health initiative aims to increase diabetes awareness and screening rates, targeting a 60% awareness rate among adults by 2030 [12][13]. - The guidelines emphasize the importance of regular blood sugar testing for high-risk groups and the need for improved healthcare capabilities at the grassroots level [12][13].